Since 1967, the lives of countless babies have been saved by the pioneering Rh Program - and to date, over three million doses of anti-D have been given to Rh negative women.
The Blood Service has recently published the results of our recently completed hepatitis E virus (HEV) RNA prevalence study. HEV is a known transfusion-transmissible agent.
Blood Service in Brief July Edition is here! We're celebrating 50 years of anti-D, preparing for the ISBT 128 Transition Label, helping health professionals with new audit tools and more.
The Information Standard for Blood and Transplant (ISBT) 128 is a global standard for the identification, labelling and information transfer of medical products of human origin.
Blood Prescriber App is an updated version of the Red Cell Prescriber App - and now includes platelets.
Two new calculators – the Red Cell Compatibility Calculator and the Blood Group Phenotype Frequency Calculator – are now available to use.
The Audit Tool provides health professionals with free easy-to-use online audits.
Blood Service in Brief Edition 19 is here! We reveal how O negative red cell units are being used across the country, when ISBT 128 labelling is coming, a new direction for plasma and more.
Q&A now has two new topics - warfarin reversal and pretransfusion clinical practice - to help test your knowledge of transfusion practice and patient blood management.
Public Consultation on proposed changes to the Criteria for the Clinical Use of Intravenous Immunoglobulin in Australia (the Criteria) is now open until 9 June 2017.
Feedback is now being sought from the attendees of Transfusion Update Conference 2017, which was held at Doltone House, Hyde Park, Sydney, on Thursday 27 April and Friday 28 April.
Blood Service in Brief Edition 18 is out now. Discover the lab of the future, education opportunities, some good news on Hepatitis B risk, and an international blood type mystery.